Corporate News

Ottobock & (OBCK.DE) Stock Performance

  • Closing Price: The last trade on Thursday 22 October 2026 closed at €50.00, reflecting a decline of 1.37 % from the previous 24‑hour period.
  • Volume and Market Capitalisation:
  • Shares traded: 65.5 million.
  • Market capitalisation: €3.3 billion.
  • Trading volume in the last 24 hours: €3.3 million.
  • Historical Context:
  • Since the end of September 2026, the share price has fallen 9.35 %.
  • Simple moving average (200 days): €56.23.
  • 52‑week high: €76.35 (26 November 2025).
  • 52‑week low: €45.56 (23 March 2026).

Market Overview

  • German Stock Market:
  • The TecDAX gained approximately 1.5 % on Wednesday, driven by strong performances from JENOPTIK, TeamViewer, and OHB SE.
  • The SDAX fell around 0.3 %, with Ottobock and other small‑cap names contributing to the decline.
  • Both indices remain well above their annual lows and have accumulated gains of roughly 10–12 % since the start of the year.
  • Analyst Commentary:
  • Ottobock’s recent decline is attributed to concerns about slower revenue growth and external pressures.
  • Price targets for the company have been revised downward by several analysts, maintaining a cautious outlook.
TickerDirectionCurrent Price (EUR)Market Capitalisation (EUR)
SCHOTT PHARMA & (1SXP.DE)Down 0.77 %25.553.9 bn
LEG IMMOBILI (LEG.DE)Up 4.45 %48.543.7 bn
TUI (TUI1.F)Up 1.40 %6.783.5 bn
AUMOVIO (AMV0.DE)Down 3.16 %33.153.6 bn
PUMA (PUM.DE)Up 4.08 %25.103.7 bn
  • Schott Pharma &: Announcement of a domestic IPO in Mumbai, targeting a raise of approximately $400 million.
  • Leg Immobilien: Disclosure of a 20 % stake acquisition by Grand City Properties, increasing that holder’s voting rights to just over 20 %.
  • TUI: Regulatory filings revealing short‑sale positions ranging from 0.7 % to 1.5 % of outstanding shares by major asset managers.
  • Aumovio: Continued underperformance in the MDAX with modest net short‑position activity.
  • Puma: Leadership change with Dennis Tao elected chairman; new board member Jeanne Huang appointed.

The information presented is based on publicly available market data and regulatory filings as of the specified dates.